147
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Clinical Profile, Systemic Association, Treatment and Visual Outcome of Patients with Scleritis in an Eye Care Center in Mexico City

, , ORCID Icon, &
Pages 550-555 | Received 02 Jul 2021, Accepted 01 Feb 2022, Published online: 08 Mar 2022

References

  • Nevares A, Raut R, Libman B, Hajj-Ali R. Noninfectious autoimmune scleritis: recognition, systemic associations, and therapy. Curr Rheumatol Rep. 2020;22(4). doi:10.1007/s11926-020-0885-y.
  • Smith JR, Mackensen F, Rosenbaum JT. Therapy Insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Pract Rheumatol. 2007;3(4):219–226. doi:10.1038/ncprheum0454.
  • Artifoni M, Rothschild PR, Brézin A, Guillevin L, Puéchal X. Ocular inflammatory diseases associated with rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:108–116.
  • Sims J. Scleritis: presentations, disease associations and management. Postgrad Med J. 2012;88(1046):713–718. doi:10.1136/postgradmedj-2011-130282.
  • Jain V, Garg P, Sharma S. Microbial scleritis - Experience from a developing country. Eye. 2009;23:255–261.
  • Stem MS, Todorich B, Faia LJ. Ocular pharmacology for scleritis: review of treatment and a practical perspective. J Ocul Pharmacol Ther. 2017;33:240–246.
  • Dutta Majumder P, Agrawal R, McCluskey P, Biswas J. Current approach for the diagnosis and management of noninfective scleritis. Asia-Pac J Ophthalmol. 2020;10(2):212–223. doi:10.1097/APO.0000000000000341.
  • Sainz De La Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis therapy. Ophthalmology. 2012;119:51–58.
  • Tanaka R, Kaburaki T, Ohtomo K, et al. Clinical characteristics and ocular complications of patients with scleritis in Japanese. Jpn J Ophthalmol. 2018;62(4):517–524.
  • Keino H, Watanabe T, Taki W, Nakashima C, Okada AA. Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol. 2010;94(11):1459–1463. doi:10.1136/bjo.2009.171744.
  • Yang P, Ye Z, Tang J, et al. Clinical features and complications of scleritis in Chinese patients. Ocul Immunol Inflamm. 2018;26(3):387–396.doi:10.1080/09273948.2016.1241282.
  • Lane J, Nyugen E, Morrison J, et al. Clinical features of scleritis across the Asia-Pacific region. Ocul Immunol Inflamm. 2019;27(6):920–926.doi:10.1080/09273948.2018.1484496.
  • El Latif E A, Seleet MM, El Hennawi H, et al. Pattern of scleritis in an Egyptian cohort. Ocul Immunol Inflamm. 2019;27(6):890–896.doi:10.1080/09273948.2018.1544372.
  • Murthy SI, Das AV, Kammari P, et al. Patterns of non-infectious scleritis across a tertiary eye care network using the indigenously developed electronic medical record system-eyesmart. Ocul Immunol Inflamm. 2021;1–7.doi:10.1080/09273948.2021.1942497.
  • Sainz De La Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical characteristics of a large cohort of patients with scleritis and episcleritis. Ophthalmology. 2012;119:43–50.
  • Al Barqi M, Behrens A, Alfawaz AM. Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia. Int J Ophthalmol. 2015;8(6):1215–1219. doi:10.3980/j.issn.2222-3959.2015.06.25.
  • Perez VL, Azar DT, Foster CS. Sterile corneal melting and necrotizing scleritis after cataract surgery in patients with rheumatoid arthritis and collagen vascular disease. Semin Ophthalmol. 2002;17:124–130.
  • Ramenaden ER, Raiji VR. Clinical characteristics and visual outcomes in infectious scleritis: a review. Clin Ophthalmol. 2013;7:2113–2122.
  • Kaçmaz RO, Kempen JH, Newcomb C, et al. Cyclosporine for ocular inflammatory diseases. Ophthalmology. 2010;117(3):576–584.
  • Gangaputra S, Newcomb CW, Liesegang TL, et al. Methotrexate for ocular inflammatory diseases. Ophthalmology. 2009;116(11):2188–2198.e1.
  • Cheung CMG, Murray PI, Savage COS. Successful treatment of Wegener’s granulomatosis associated scleritis with rituximab [13]. Br J Ophthalmol. 2005;89:1542.
  • Iaccheri B, Androudi S, Bocci EB, Gerli R, Cagini C, Fiore T. Rituximab treatment for persistent scleritis associated with rheumatoid arthritis. Ocul Immunol Inflamm. 2010;18:223–225.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.